Adagio Medical Holdings (ADGM) Raw Materials (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Raw Materials data on file, last reported at $1.4 million in Q1 2026.

• Raw Materials for Q1 2026 came in at $1.4 million, down 11.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 million (down 11.54% YoY), and the FY2025 annual result was $1.4 million, down 15.45% from the prior year.
• Raw Materials declined to $1.4 million in Q1 2026 per ADGM's latest filing, from $1.4 million in the prior quarter.
• Over five years, Raw Materials peaked at $2.5 million in Q3 2024 and troughed at $1.4 million in Q1 2026.
• A 4-year average of $1.7 million and a median of $1.6 million in 2025 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2025 and 2026: Raw Materials plunged 45.15% in 2025, then decreased 11.54% in 2026.
• A 4-year view of Raw Materials shows it stood at $2.2 million in 2023, then fell by 23.88% to $1.7 million in 2024, then fell by 15.45% to $1.4 million in 2025, then slipped by 4.15% to $1.4 million in 2026.
• Business Quant data shows ADGM's Raw Materials at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.